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Hepatitis C virus (HCV) is a global health problem.
Designing therapeutic agents that target HCV’s
RNA genome remains challenging. HCV genomic
RNA is large and highly structured with long-range
genome-scale ordered RNA structures. Predicting
the secondary- and tertiary-structure elements that
reveal the accessibility of target sites within HCV
RNA is difficult because of the abundance of long-
range interactions. Target site accessibility remains
a significant barrier to the design of effective thera-
peutics such as small interfering RNAs (siRNAs)
against different strains of HCV. Here we developed
two methods that interrogate the folding of HCV RNA,
an approach involving viral RNA microarrays (VRMs)
and an HCV viral RNA-coated magnetic bead-based
(VRB) assay. VRMs and VRBs were used to deter-
mine target site accessibility for siRNAs designed
against the HCV genome. Both methods predicted
potency of siRNAs in cell-culture models for HCV
replication that are not easily predicted by informatic
means.
INTRODUCTION
Hepatitis C virus (HCV) infection is a rapidly increasing global
health concern, with over 200 million people infected worldwide.
In most infected individuals, HCV establishes a chronic infection
that can lead to cirrhosis, hepatocellular carcinoma, and death.
Currently, there is no vaccine available and antiviral therapy,
which consists of combination therapy with pegylated-IFNa 2a
and ribavirin, achieves sustained response rates in only approx-
imately 50% of infected patients (McHutchison et al., 2006).
Although new antiviral agents are in development, the rapid
development of resistance suggests that multiple drugs may
be needed to limit the emergence of drug-resistant strains
(Randall et al., 2003). There is thus an urgent need to develop
effective preventative and alternative therapeutic strategies for
HCV infection.Chemistry & Biology 17,HCV is a positive-sense RNA virus that replicates through
a double-stranded (ds) RNA intermediate in the cytoplasm of
host cells. Its genome encodes an3000 amino acid polyprotein
which is cleaved, by host and viral proteases, into three struc-
tural proteins (core, E1, and E2) and seven nonstructural proteins
(p7, NS2, NS3, NS4A, NS4B, NS5A, and NS5B). As for all RNA
viruses, the positive-sense HCV RNA genome serves as
a template for translation, negative-strand synthesis, and pack-
aging into virions. A number of well-defined cis-acting RNA
elements have been identified that mediate these processes
during the HCV life cycle (Le et al., 1995; Tanaka et al., 1995,
1996; Wang et al., 1995; Wang and Siddiqui, 1995; Kolykhalov
et al., 1996; Blight and Rice, 1997; Friebe et al., 2001, 2005;
Friebe and Bartenschlager, 2002; Kim et al., 2002; Tuplin et al.,
2002, 2004; Lee et al., 2004; You et al., 2004; McMullan et al.,
2007; Diviney et al., 2008; You and Rice, 2008). In addition,
Simmonds and colleagues have recently used increasingly
advanced computational approaches to provide evidence for
evolutionarily conserved, genome-scale ordered RNA structures
(GORS) of yet unknown function within the genome of HCV and
a number of other diverse RNA viruses from plants and animals
(Simmonds, 2004; Davis et al., 2008). This suggests that target
site accessibility may be an important factor when designing
therapeutics that target these highly structured viral genomes,
including small RNA species such as small interfering RNAs
(siRNAs). HCV is a particularly attractive target for siRNA-based
antiviral therapy because it is a cytoplasmically replicating,
single-stranded RNA virus whose genome functions as both an
mRNA and the template for viral replication.
The RNA silencing pathway uses the RNA-induced silencing
complex (RISC) and siRNA duplexes to target complementary
mRNAs for endonucleolytic cleavage (Fire et al., 1998; Zamore
and Haley, 2005). It has recently been demonstrated that the
folded state of the target mRNA can hamper the effectiveness
of siRNAs considerably (Holen et al., 2002; Bohula et al., 2003;
Kretschmer-Kazemi Far and Sczakiel, 2003; Vickers et al.,
2003; Xu et al., 2003; Brown et al., 2005; Tafer et al., 2008; Watts
et al., 2009). An innovative method called RNAxs has been devel-
oped in an attempt to address the issue of target site accessi-
bility in mRNAs (Tafer et al., 2008); however, this method cannot
account for the large amount of secondary structure present in
the highly complex genomes of RNA viruses and has thus far
been applied only to cellular mRNAs. Another innovative method515–527, May 28, 2010 ª2010 Elsevier Ltd All rights reserved 515
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Figure 1. AFM of HCV RNA
HCV RNAs appeared as tightly packed clusters
upon deposition, indicating that the tertiary
interactions remain intact in the collapsed state.
HCV RNAs had diameters of approximately
80–120 nm. The Z scale ranges from 0 to 10 nm.
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analyzed by primer extension (SHAPE) was employed to charac-
terize secondary-structure elements within the entire genome of
HIV-1 (Watts et al., 2009). Watts et al. were able to correlate HIV-
1mRNA evolutionarily conserved structural elements with folded
domains in their respective protein products, implying a role for
the folding of genomic RNA in assisting with protein folding
during translation (Watts et al., 2009). This approach, although
highly innovative, is not designed for the interrogation of target
site accessibility of siRNAs. In addition, HCV genomic RNA
contains a larger amount of structured RNA or GORS than the
HIV-1 genome (Simmonds et al., 2004; Davis et al., 2008).
In this study, we sought to investigate the importance of target
RNA structure for the effectiveness of siRNAs directed against
the highly structured HCV genome. We demonstrate that
in vitro hybridization assays can be used to predict the effective-
ness of HCV-specific siRNAs in cell culture. Our results suggest
that target site accessibility may be a particularly important
parameter for the design of effective siRNAs against the large,
highly structured genomes of positive-sense RNA viruses, and
have implications for the design and screening of highly effective
siRNAs against such targets.RESULTS
HCV Replicon RNA Retains a Complex Folded Structure
upon Deposition
To investigate the physical nature of the highly structured HCV
replicon RNA, HCV replicon RNA transcripts were directly
visualized by atomic force microscopy (AFM). AFM has been
extensively used in the study of DNA (Umemura et al., 2000;
Hansma et al., 2004; Liu et al., 2005) and, more recently, has
beenextended to the investigationof large-scale secondarystruc-
ture of RNAs (Drygin et al., 1998; Hansma et al., 1999, 2003, 2004;
Giro et al., 2004; Alvarez et al., 2005; Kuznetsov et al., 2005;
Noestheden et al., 2007; Davis et al., 2008). Upon imaging, the
HCV replicon RNA transcripts uniformly adopted a tightly packed
condensed state that was largely maintained during the deposi-
tion process (Figure 1). HCV replicon RNAs had a regular unit
size with amean radii for the x and y axes of approximately 30 nm
and mean heights of 3.9 ± 1.0 nm (n = 10). This indicates that,
under appropriate conditions, HCV replicon RNA can be spotted
onto surfaces in a complex, highly folded conformation that may
be representative of the native conformation.516 Chemistry & Biology 17, 515–527, May 28, 2010 ª2010 Elsevier Ltd All rights reservedDesign of siRNAs against HCV
Replicon RNA
Once it was demonstrated that the HCV
replicon RNA could be spotted in
a complex, highly folded conformation,
we wanted to further investigate whetherhybridization to spotted HCV replicon RNAs could be used to
predict the potency of HCV replicon-specific siRNAs. Synthetic
siRNAs were thus designed targeting different regions of the
HCV replicon RNA (Figure 2). siRNAs were designed using
the rules outlined by Reynolds and colleagues (Reynolds
et al., 2004) and had similar G+C contents to ensure equal
binding strengths irrespective of the overall base composition
of the siRNAs (Figure 2). The siRNAs were named according
to their nucleotide location in the subgenomic replicon RNA
(Figure 2). As controls, two previously characterized HCV-
specific siRNAs were used: IRES-331 siRNA directed against
the HCV internal ribosomal entry site (IRES) region of the
HCV replicon RNA (Yokota et al., 2003), and NS5B-7256 siRNA,
a highly potent siRNA directed against the NS5B region of the
replicon RNA (Wilson et al., 2003). As a negative control, GL3
siRNA was used, which has no sequence complimentarity to
HCV replicon RNA. Finally, as a control for target site accessi-
bility, an siRNA (SL3.3-8589) was designed against the 50 arm
of a known stem-loop region (SL3.3) in the NS5B open reading
frame (You et al., 2004; Friebe et al., 2005). All siRNAs were
fluorophore conjugated at the 50 end of their antisense (guide)
strands so that hybridization could be monitored by
fluorescence.
Hybridization of siRNAs to Viral RNA Microarrays
Is Restricted by Target Site Accessibility
To investigate the ability of hybridization to spotted HCV replicon
RNA to differentiate between accessible and inaccessible target
RNA sequences, we prepared viral RNA microarrays (VRMs).
VRMs were prepared by spotting the HCV replicon RNA under
native conditions on epoxysilane-coated glass slides. The target
RNA was diluted in native spotting buffer and was printed in
quadruplicate in increasing concentrations on the microarray
from 5 to 500 ng/ml (Figure 3A). As negative and positive controls,
oligonucleotides complementary to Campylobacter jejuni genes
were spotted in duplicate (negative control) or quadruplicate
(positive controls) in the microarrays at a concentration of
500 ng/ml (Figure 3A). The Cy3 channel (left) shows hybridization
of the Cy3-labeledC. jejuniDNA controls and hybridization of the
guide strand of NS5B-7256 siRNA to the HCV replicon RNA,
whereas the Cy5 channel (right) represents hybridization of the
Luc988-42 nt DNA control probe to the luciferase region of the
HCV replicon RNA, which was used to normalize the data
(Figure 3A).
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Figure 2. HCV-Specific siRNAs
(A) Schematic diagram of the HCV subgenomic replicon
showing the approximate location of the HCV-specific siRNAs
(red). The Cy5-labeled Luc988-42 nt DNA control probe loca-
tion is indicated in purple.
(B) HCV-specific siRNA sequences and their positions in the
HCV subgenomic replicon RNA.
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distinguish between accessible and inaccessible targets, hybrid-
ization of the positive- and negative-control single-stranded flu-
orophore-labeled antisense (guide) siRNAs was carried out
under native and denaturing conditions (Figure 3B). Under native
conditions, regions of the HCV replicon RNA with a high degree
of stable internal base pairing should adopt a closed configura-
tion and be relatively inaccessible to guide strand hybridization.
In contrast, the relatively unstructured regions of the HCV repli-
con RNA should be relatively accessible and lead to a greater
degree of hybridization. Under denaturing conditions, the inac-
cessible regions should become unpaired, resulting in an open
conformation that should have a similar degree of hybridization
to the accessible regions. The NS5B-7256 siRNA has previously
been described as a highly potent siRNA against HCV replicon
RNA (>90% reduction in HCV replicon RNA 72 hr posttransfec-
tion) (Wilson et al., 2003); as such, it is likely to have a highly
accessible target within the HCV replicon RNA. In agreement
with this, hybridization of this siRNA guide strand to the VRMs
yielded similar normalized net intensities under native and dena-
turing conditions (Figure 3B). In contrast, the SL3.3-8589 siRNA,
designed against the 50 arm of a known stem-loop region (SL3.3)
in the HCV replicon RNA (You et al., 2004; Friebe et al., 2005),
should be largely inaccessible to hybridization. Under native
conditions, the normalized net intensities of SL3.3-8589 siRNA
guide-strand hybridization were approximately 40% of that
observed under denaturing conditions (Figure 3B), suggesting
that hybridization of guide-strand siRNAs to the VRMs is
restricted by target site accessibility under native conditions.
Using the VRMs, the accessibility of all of the HCV-specific
siRNA guide strands was analyzed by quantifying their hybrid-
ization under native conditions (Figure 3C). Hybridization
intensities of the different siRNAs were scaled according to
standard amounts of DNA oligonucleotide controls to give the
normalized net intensities, and all siRNA guide strands wereChemistry & Biology 17, 515–527, Mahybridized in triplicate. The positive-control
NS5B-7256 siRNA gave the highest signal inten-
sity, whereas the negative-control GL3 siRNA,
with no sequence complementarity to the HCV re-
plicon RNA, had negligible signal intensity similar
to background (see Hyb Buffer, Figure 3C). The
NS5B-8136, NS5A-5567, and NS3-2904 siRNA
had the next highest signal intensities, with
normalized net intensities 78.7%, 72.6%, and
62.2% of the positive-control NS5B-7256 siRNA,
respectively. This was followed by the negative
control for target site accessibility, SL3.3-8589
siRNA (49.2%), and the NS4B-5027 siRNA(30.3%). The low signal intensity of the NS4B-5027 siRNA
suggests that this siRNA may be directed against an inacces-
sible target site within the HCV replicon RNA.Hybridization of siRNAs to VRBs Is Restricted by Target
Site Accessibility
To further demonstrate that hybridization of guide-strand siRNAs
to HCV replicon RNA under native conditions is restricted by
target site accessibility, we extended our hybridizations to a solu-
tion-based approachmore representative of the situation in vivo.
The HCV replicon RNA was first end labeled with maleimide-
PEG11-biotin and then hybridized to fluorophore-conjugated
siRNAs under native or denaturing conditions in solution. The
hybridized HCV replicon RNA was then captured on streptavi-
din-coated magnetic microbeads and imaged using
fluorescence microscopy to assess target site accessibility
(Figure 4A). The HCV-specific siRNAs were hybridized in
increasing concentrations under native and denaturing condi-
tions. To account for any nonspecific binding of the siRNAs to
the beads, reactions were also carried out in the absence of
HCV replicon RNA. Representative images from each of the
siRNA hybridizations are shown in Figure 4B.
Quantification of signal intensities from individual beads per
image (n = 100) using increasing concentrations of siRNAs
(10 nM to 1 mM) was used to generate line graphs for siRNAs
during native and denaturing hybridizations (Figure 5A). The
net integrated optical density (IOD) of SL3.3-8589 siRNA
guide-strand hybridization was approximately 18% of that
observed under denaturing conditions, whereas the net IOD of
the NS5B-7256 siRNA guide strand was largely unchanged
under native and denaturing conditions (Figure 5B). This
suggests that, like the VRMs, hybridization of guide-strand
siRNAs to viral RNA-coated magnetic bead-based (VRB) assays
is restricted by target site accessibility under native conditions.y 28, 2010 ª2010 Elsevier Ltd All rights reserved 517
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Figure 3. Viral RNA Microarrays
(A) Schematic diagram of the VRM design and
a representative VRM hybridization. After hybrid-
ization of HCV-specific siRNAs, slides were
scanned using a microarray scanner, resulting in
images of the siRNA and DNA positive controls
in the Cy3 channel (middle) and the Luc988-
42 nt control probe in the Cy5 channel (right)
that were used in the normalization of the micro-
array data. A representative hybridization of
NS5B-7256 siRNA is shown.
(B) Hybridization to VRMs under native and dena-
turing conditions. The normalized net intensities
(Cy3/Cy5) of the positive-control NS5B-7256
siRNA and the negative-control SL3.3-8589
siRNAs are shown. Error bars represent SE.
(C) Hybridization of the HCV-specific siRNAs
to VRMs under native conditions. The data
represent the average of two independent hybrid-
izations, and normalized net intensities (Cy3/Cy5)
from a single HCV replicon RNA concentration
(125 ng/ml) are shown. Error bars represent SE.
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strands was analyzed by quantifying their hybridization to the
HCV replicon RNA in solution under native and denaturing
conditions (Figure 5C). The net IODs from the image analyses
were used to generate curves of the native and denaturing
hybridizations for each siRNA. The ratio of the slope of the native
hybridization to the denatured hybridization for each siRNA was
used as a measure of target site accessibility (Figure 5C). The
positive-control NS5B-7256 siRNA gave the highest signal inten-
sity, with a ratio of 0.87 ± 0.16, whereas the negative-control GL3
siRNA, with no sequence complementarity to the HCV replicon
RNA, had negligible signal similar to background (0.008 ±
0.001; Figure 5C). The NS5B-8136 and NS3-2904 siRNAs had
the next highest ratios, with ratios of 0.75 ± 0.08 and 0.77 ±
0.13, respectively. The NS5A-5567 and IRES-331 siRNAs had
intermediate signals, with ratios of 0.36 ± 0.12 and 0.25 ± 0.06,
respectively. Finally, the NS4B-5027 and SL3.3-8589 had low
signal intensities, with ratios of 0.21 ± 0.06 and 0.15 ± 0.08,
respectively (Figure 5C). The intermediate and low signal intensi-
ties likely represent intermediate accessibility of the siRNA target
sites within the native HCV replicon RNA structure.
Prediction of siRNA Potency Based on Target Site
Accessibility Correlates with siRNA Knockdown
in Cell Culture
To correlate the target site accessibility predictions from the
VRMs and VRBs to siRNA knockdown in cell culture, the effect
of each of the HCV-specific siRNAs on HCV protein and replicon
RNA levels was examined by western and northern blot analyses
from siRNA duplex transfection of Huh-7 cells stably harboring
HCV subgenomic replicon RNA (Figures 6A and 6B). The levels
of the HCV NS5A protein correlated well with the amount of518 Chemistry & Biology 17, 515–527, May 28, 2010 ª2010 Elsevier Ltd All rights reservedHCV replicon RNA, suggesting that the
siRNAs are functioning by an RNA
cleavage-based mechanism rather than
translational repression in cell culture.For a more quantitative approach to assessing siRNA knock-
down, we used quantitative real-time polymerase chain reaction
(qPCR) analyses to quantify the levels of HCV replicon RNA after
siRNA duplex treatment of Huh-7 cells stably harboring HCV
subgenomic replicon RNA (Figure 6C). Treatment with interferon
g (IFNg) served as a positive control for knockdown of HCV repli-
con RNA, reducing the levels of the HCV replicon RNA6.7-fold
compared to mock-treated samples. The NS3-2904, NS5B-
7256, and NS5B-8136 siRNAs all reduced HCV replicon RNA
levels to a similar degree, with mean fold reductions of 5.1-,
4.9-, and 5.0-fold, respectively (Figure 6C). The IRES-331 and
NS5A-5567 siRNAs had intermediate knockdowns of 2.5- and
2.2-fold, respectively, whereas the NS4B-5027 and SL3.3-
8589 siRNAs both reduced HCV RNA levels by only 1.5-fold
(Figure 6C). The negative-control (GL3) siRNA did not have
a significant effect on the levels of the HCV NS5A protein
(Figure 6A) or the replicon RNA (Figures 6B and 6C), indicating
that the effects of the siRNAs on HCV protein and RNA levels
are sequence specific and are not caused by induction of the
nonspecific IFN response. This is consistent with other findings
that dsRNAs < 30 nt do not induce significant IFN responses
(Minks et al., 1979; Manche et al., 1992). Thus, the effects of
the designed siRNAs on HCV protein and RNA levels seem to
be the result of siRNA-directed degradation of HCV replicon
RNA by HCV-specific siRNA-loaded RISC.
DISCUSSION
Spotting HCV Replicon RNA in a Native Conformation
for VRMs
The high resolution possible with AFM provides a means to
directly visualize deposited HCV replicon RNA at the molecular
Biotin-conjugated 
HCV RNA
Fluorescently 
labeled siRNA
Streptavidin 
microbead
Incubate Capture
Assess target site 
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A
B
No HCV 
RNA
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Figure 4. Viral RNA Beads
(A) Schematic diagram of hybridization of siRNAs to biotin-conjugated HCV replicon RNA and capture on magnetic microbeads. Biotin-labeled HCV replicon
RNAs are first incubated under native or denaturing conditionswith fluorophore-conjugated siRNAs. The hybridized siRNAs are then captured onmagnetic strep-
tavidin-conjugated microbeads. The beads are washed and then target site accessibility is assessed by fluorescence microscopy.
(B) Representative fluorescence images of VRBs after hybridization with 100 nM siRNAs under native and denaturing conditions. ‘‘No HCV RNA’’ represents
hybridization reactions carried out in the absence of HCV replicon RNA in order to assess nonspecific binding of the siRNAs to the beads.
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Target Site Accessibility in Hepatitis C Viruslevel (Rivetti et al., 1996; Hansma et al., 2003; Alvarez et al.,
2005; Kuznetsov et al., 2005; Noestheden et al., 2007).
Previous studies have used AFM analyses to visualize specific
RNA-RNA interactions such as kissing-loop interactions
(Hansma et al., 2003) or RNA virus genome circularization
(Alvarez et al., 2005) and, more recently, we and others have
used it to visualize the larger-scale shape of RNA molecules
(Kuznetsov et al., 2005; Noestheden et al., 2007; Davis et al.,
2008). We have previously demonstrated that HCV RNA
exhibits more complex tertiary structure than other RNA virus
genomes, as measured by AFM (Davis et al., 2008). In the
current study, it was demonstrated that HCV RNA can be
spotted in a very regular, tightly packed condensed state
(Figure 1).
Despite the high resolution of this technique, AFM does
introduce artifacts associated with the deposition process,
most notably the flattened appearance of the RNAs (i.e., the
measured x and y diameters are approximately 15 times
greater than their height) (Rivetti et al., 1996; Hansma et al.,
2003; Davis et al., 2008). This is likely due to the partial disso-
lution of the condensed state resulting from interactions with
surface divalent metal ions during drying of the samples
(Noestheden et al., 2007; Davis et al., 2008). Nevertheless,
the AFM imaging revealed a regular, tightly packed condensed
structure of the HCV replicon RNA with many of the tertiary
structures remaining intact, despite the shape distortions that
likely arise during AFM.Chemistry & Biology 17,VRMs and VRBs Are Restricted by Target Site
Accessibility
Traditional microarray experiments are based on duplex stability
(thermodynamics) between the nucleic acid probe and its target.
They are typically carried out close to the melting temperature of
the specific nucleic acid probe-target interaction under condi-
tions which destroy the less-stringent secondary structures
that may be present in the target. The VRMs described herein
differ from traditional microarrays in that they are carried out
under native conditions meant to preserve the secondary and
tertiary structure of the target RNA. In this way, VRMs are
a measure of hybridization speed (kinetics) of the siRNA-target
interaction and reflect the accessibility of the folded state of
the RNA target.
Hybridization of HCV-specific guide-strand siRNAs to HCV
VRMs was used as a measure of target site accessibility. Using
the control siRNAs, we were able to demonstrate that hybridiza-
tion to the VRMs under native conditions was restricted by target
site accessibility (Figure 3B). This was also reflected in the
hybridization studies carried out in solution, on VRBs, which
may more closely represent the native environment of the HCV
replicon RNA in vivo (Figures 5A and 5B). Hybridization of the
whole panel of HCV-specific siRNAs demonstrated that the
NS3-2904, NS5B-7529, and NS5B-8136 siRNAs had relatively
high hybridization intensities under native conditions, suggesting
their target sites are likely to be relatively accessible in the native
HCV replicon RNA (Figures 3C and 5C). The NS5A-5567 siRNA515–527, May 28, 2010 ª2010 Elsevier Ltd All rights reserved 519
Figure 5. VRB Data Analysis
(A) Quantification of net IODs from individual
beads (n = 100) from images of increasing siRNA
concentrations was used to generate line graphs
of signal intensities under native (closed circles)
and denaturing (open circles) conditions. Line
graphs of the positive-control NS5B-7256 (left)
and negative-control SL3.3-8589 (right) siRNAs
are shown. Error bars represent SE.
(B) Hybridization to VRBs under native and dena-
turing conditions. The slopes of the standard
curves generated in (A) were used to generate
a bar graph of the positive-control NS5B-7256
and negative-control SL3.3-8589 siRNA hybridiza-
tions to the VRBs under native and denaturing
conditions. Error bars represent SE.
(C) Ratio of slopes from native and denaturing
hybridization of the HCV-specific siRNAs to
VRBs. The data represent the average of three
independent hybridizations, and net IODs from
image analyses were used to calculate the slopes
for native and denaturing hybridizations. Error bars
represent SD of at least three independent repli-
cates.
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5027 siRNA had relatively low hybridization intensities similar
to that of the SL3.3-8589 siRNA. This suggests that in addition
to the IRES-331 and SL3.3-8589 siRNAs that are directed
against known structured regions in the HCV genome, NS4B-
5027 is also likely to have a relatively inaccessible target site
within the native HCV replicon RNA (Figures 3C and 5C).
The minimal hybridization seen with the NS4B-5027 siRNA is
likely to be due to the highly structured nature of HCV replicon
RNA. Alternatively, it cannot be ruled out that the apparent inac-
cessibility of this siRNA could be a result of a ‘‘shell’’ of folded
RNA shielding an unfolded core of unstructured RNA within the
3D conformation of the RNA. However, Simmonds and
colleagues have previously investigated this possibility for the
HCV RNA genome in their investigation of GORS (Davis et al.,
2008). By creating chimeric viral RNAs where a region of the rela-
tively unstructured Bunyavirus (BV) RNA (non-GORS) was in-
serted into the HCV viral RNA (GORS), they were able to demon-
strate that insertions into the RNA genome did not affect the
accessibility of the surrounding regions to probe hybridization
(Davis et al., 2008). The same was true for the reverse chimera
(i.e., where regions of the HCV RNA genome were inserted into
the BVRNA genome), arguing against the shell hypothesis (Davis
et al., 2008).
The results obtained from the VRMs and VRBs qualitatively
correlate with one another, validating our hypothesis that the
spotting of HCV RNA under native folding conditions mimics
the native, folded state in solution (measured by VRBs). The
advantages of using both VRMs and VRBs are that these
approaches are high throughput and have the capacity to be
adapted to other RNA viruses as well as other nucleic acid inter-
actions, and that they involve the use of small quantities of520 Chemistry & Biology 17, 515–527, May 28, 2010 ª2010 Elsevierreagents and rapidly result in empirical data on target site acces-
sibility. The additional advantage of using VRBs is that they are
likely more representative of the true folded state, unencum-
bered by surface effects that might arise during spotting and
hybridization procedures on the surface of glass slides.
Correlating Target Site Accessibility to Silencing
in Cell Culture
The results from hybridizations to VRMs and VRBs largely corre-
lated with the potency of the siRNAs in cell culture (Figure 7). The
pattern of potency of the siRNAs is unlikely to be due to the
kinetics of silencing because western and northern blots
prepared from 24, 48, and 72 hr posttransfection resulted in
similar patterns of siRNA silencing (data not shown). The HCV-
specific siRNAs with high target site accessibility tended to
silence HCV protein expression and replicon RNA levels quite
efficiently, whereas those predicted to be target inaccessible
by in vitro hybridization tended to have little effect on HCV
protein and replicon RNA levels (Figure 6). This is despite the
fact that in both cases the composition of the hybridization buffer
does not reflect the protein-rich cytosolic environment of the cell.
In the future, it will be interesting to include host or viral proteins
in the hybridization reactions to identify specific protein-RNA
interactions.
Implications for siRNA Design
Many factors contribute to the overall efficiency of RNA
silencing. The majority of available siRNA design software use
eight parameters that, when incorporated into a rational siRNA
design algorithm, increase the probability of selecting an effec-
tive siRNA (i.e., one capable of silencing gene expression
by >50%) (Elbashir et al., 2002; Reynolds et al., 2004). TheseLtd All rights reserved
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Figure 6. Analysis of siRNA Knockdown in Cell Culture
(A) Western blot analysis of HCV NS5A protein levels in HCV subgenomic
replicon-harboring cells 48 hr posttransfection with HCV-specific siRNAs.
Samples from the parental Huh-7 cells (lane 1) and replicon-harboring cells
(lane 2) are shown. Mock-transfected samples (lane 3, transfection reagent
only) and samples transfected with the negative-control (GL3, lane 4) and
HCV-specific siRNAs (lanes 5–11) are shown. IFNg was used as a positive
control for knockdown of HCV NS5A protein and replicon RNA.
(B) Northern blot analysis of HCV replicon RNA levels in HCV subgenomic
replicon-harboring cells 48 hr posttransfection with HCV-specific siRNAs.
The samples analyzed by northern blot are identical to those described for (A).
(C) qPCR analysis of siRNA knockdown in cell culture. Data are represented as
mean fold reduction in HCV replicon RNA relative to mock-treated samples.
Experimental replicates were performed in triplicate and error bars represent
SD.
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2002; Holen et al., 2002; Reynolds et al., 2004), low internal
stability of the 30 terminus of the sense (passenger) strand
(Khvorova et al., 2003; Schwarz et al., 2003; Reynolds et al.,
2004), lack of internal repeats (Reynolds et al., 2004), an A
base at position 19 (sense strand), an A base at position 3 (sense
strand), a U base at position 10 (sense strand), a base other than
G or C at position 19 (sense strand), and a base other than G at
position 13 (sense strand) (Elbashir et al., 2002; Reynolds et al.,
2004). In these algorithms, the only measure of target site acces-
sibility is based on G+C contents, as G+C contents of 30%–64%
have been demonstrated to correlate with accessibility (Elbashir
et al., 2002; Reynolds et al., 2004); however, relying on G+C
content alone results in a large number of predicted false nega-
tives (Heale et al., 2005).
In this study, despite a rational approach to siRNA design, only
a fraction of the siRNAs were effective at reducing the expres-
sion of the HCV replicon RNA, with the efficiency of the different
siRNAs varying significantly. The efficiency of knockdown in cell
culture did not correlate with any of the parameters outlined byChemistry & Biology 17,Reynolds and colleagues (Reynolds et al., 2004), including
melting temperature or G+C content. Additional parameters
must therefore affect the efficiency of siRNAs for HCV knock-
down.
Efficiency of loading into the RISC could also potentially
contribute to differences in silencing efficiency of HCV-specific
siRNAs (MacRae et al., 2008). To investigate this possibility,
we explored the ability of recombinant human argonaute
2 (hAGO2) to load the HCV-specific siRNAs in vitro. The majority
of the siRNAs were efficiently loaded into hAGO2 after a 30 min
incubation period (>75% for seven of the eight siRNAs) and the
slight variations in loading did not correlate with silencing
efficacy, arguing against the efficiency of RISC loading as
a contributing factor to silencing efficiency in this case. However,
the contribution of other cellular RNA silencing pathway compo-
nents to the efficiency of RISC loading cannot be ruled out within
the complex environment of the cell. Nevertheless, due to the
rational design of the siRNAs with similar G+C contents, it is
unlikely that there are dramatic differences in the ability of
RISC to unwind the siRNA duplexes in cell culture.
A few groups have now described algorithms that take into
account local secondary-structure prediction in siRNA design
that have improved the probability of designing effective siRNAs
(Heale et al., 2005; Overhoff et al., 2005; Tafer et al., 2008;
Varekova et al., 2008). However, for long RNA targets, the
prediction accuracy of currently available computational algo-
rithms is still very low, generating numerous alternative struc-
tures (Luo and Chang, 2004; Schubert et al., 2005). In addition,
the prevalence of long-range RNA-RNA interactions in the
genomes of RNA viruses is not yet amenable to accurate
modeling. In order to test the ability of secondary-structure
prediction to predict the accessibility of the siRNA targets in
HCV replicon RNA, we carried out phylogenetic covariation anal-
yses by folding energy scans of the 83 available HCV 1b
sequences using Simmonic (Simmonds et al., 2004; Davis
et al., 2008), which utilizes UNAfold for prediction of secondary
structure (Markham and Zuker, 2005) (Figure 7). We carried out
our analyses on all of the known HCV genotype 1b sequences
rather than just the HCV replicon RNA used in this study, as
the homologous genotype 1b RNAs are similar enough to form
the same structure but exhibit polymorphisms which can be
informative. Mean free energy of folding difference (MFED)
scores of the siRNA target sites and the regions 30 nt adjacent
to them did not correlate with their knockdown efficiencies
(Figure 7). In fact, the NS5B-8136 siRNA was predicted to target
a relatively structured region although it was one of the most
potent siRNAs in cell culture (Figure 6). Hence, reliable results
of analyses based on computational secondary-structure
prediction cannot be guaranteed for such targets (Luo and
Chang, 2004).
The native hybridization-based methods described herein
thus represent a rapid high-throughput approach to screening
for effective siRNAs against the highly structured HCV RNA
genome and has the potential to be applied to other RNA-RNA
interactions, including the genomes of other highly structured
positive-sense RNA viruses. Although we only investigated inter-
actions with the Con1 HCV 1b genomic sequence in this study,
the high-throughput nature of this approach makes it easy to
apply it to all 83 known clinical variants of the HCV genotype515–527, May 28, 2010 ª2010 Elsevier Ltd All rights reserved 521
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Figure 7. Analysis of HCV-Specific siRNA Target Sites
(A) Distribution of MFEDs across the siRNA target sites and the
adjacent 30 nt based on folding energy scans of the 83 pub-
lished HCV genotype 1b sequences available in GenBank.
Mean MFEDs (% difference in MFEs of the native and scram-
bled sequences) for the individual siRNA target sites were
calculated based on folding energy scans of aligned
sequences for consecutive 150-base fragments (in 2-base
increments). Large MFEDs indicate the target sequence is
more structured than the null expectation. siRNA target sites
are shaded in gray (nt 1–21), where 1 represents the first nucle-
otide of the siRNA target site.
(B) Schematic showing the predicted versus actual potency of
eight different siRNAs. The horizontal arrow from left to right
indicates relative potency. The predicted potencies lie above
the arrow whereas the observed potencies are located below
the arrow, with the least potent siRNAs on the left and most
potent siRNAs on the right.
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broader target site accessibility information. The latter approach
could assist in evaluating target site accessibility in highly
conserved regions of the viral genome that may not be tolerant
of escape mutations.
During natural infections, the HCV RNA genome is likely to
have a dynamic structure able to readily accommodate
unwinding, elongation, and exposure to different regions of the
RNA to viral and cellular proteins for translation and replication
of the viral genome. As a future direction, it may be interesting
to examine how specific viral or cellular proteins affect the
accessibility of the HCV replicon RNA in vitro. Addition of purified
viral or cellular proteins or extracts to the in vitro hybridization
reactions could yield new information about direct interactions
with the viral genome. For example, addition of siRNA-hAGO2
complexes could help us gain information on the accessibility
of the HCV RNA to the larger RISC rather than just the siRNA it-
self. The addition of viral proteins could help identify novel RNA-
interacting domains such as packaging signals, which have yet
to be identified for HCV. The VRB approach may be more
amenable to addition of proteins, as it can avoid the surface
effects that might result in conformational restriction of protein-
RNA interactions that can occur in the VRM approach.
The results presented here and elsewhere clearly demonstrate
that target RNA secondary structure has major consequences
for siRNA-induced gene silencing (Holen et al., 2002; Bohula
et al., 2003; Kretschmer-Kazemi Far and Sczakiel, 2003; Vickers
et al., 2003; Xu et al., 2003; Brown et al., 2005). Recent studies
have demonstrated that the structure of target RNA or the
binding of proteins can also dramatically affect microRNA
(miRNA) recognition of RNA targets (Hofacker, 2007; Kedde
et al., 2007; Kertesz et al., 2007; Long et al., 2007; Obernosterer522 Chemistry & Biology 17, 515–527, May 28, 2010 ª2010 Elsevier Ltd All rights ret al., 2008). Because miRNA-target recognition is
thought to require as little as 7 nt for targeting
(Lewis et al., 2003), hybridization of miRNAs to
VRMs or VRBs may also be useful for elucidation
of the rules governingmiRNA target site recognition
as well as conformation of bona fide miRNA target
sites.Information gained from structural probing by native hybridiza-
tion of nucleic acids may also serve as a starting point for the
design of nucleic acid-based probes to pull down or titrate out
novel interacting partners with the viral RNA genome. For
example, where the hybridization of the siRNA probes in vitro
disagrees with the silencing efficiency in cell culture, this may
indicate that the siRNA target site is occupied by a novel
protein-RNA or RNA-RNA interaction in vivo. RNA-based probes
could then be designed to pull down or titrate out the interacting
partners in the context of viral replication. RNA-based probes
have already been demonstrated to be useful for elucidating
protein-RNA or RNA-RNA interactions in a number of cellular
systems (Srisawat and Engelke, 2002; Martinez et al., 2002).
The VRM and/or VRB approaches could also be extended to
other RNA molecules, including cellular mRNAs or the RNA
genomes of other important human pathogens.
SIGNIFICANCE
Under appropriate conditions, the HCV replicon RNA can be
spotted onto surfaces in a conformation that appears to be
representative of the native conformation. Using hybridiza-
tion to native HCV replicon RNA on surfaces or in solution,
hybridization efficiency (target site accessibility) of HCV-
specific siRNAs was correlated to silencing in cell culture.
The parallels observed between in vitro hybridization and
siRNA efficiency suggest that structured RNA elements in
HCV replicon RNA is a major factor in determining the
efficiency of synthetic siRNAs. The technique described
here represents a rapid, high-throughput approach to
screen for effective siRNAs directed against the large, highly
structured HCV replicon RNA genome based on target siteeserved
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extended to other RNA-RNA interactions, including the
highly structured genomes of other important human patho-
gens and in the investigation of protein-RNA and RNA-RNA
interactions.
EXPERIMENTAL PROCEDURES
Cell Culture and HCV Replicons
The Huh-7 cell lines used in this study were cultured in Dulbecco’s modified
Eagle’s medium (Invitrogen) supplemented with 100 nM nonessential amino
acids, 50 U/ml penicillin, 50 mg/ml streptomycin, and 10% fetal bovine serum
(PAA Laboratories). G418 (Geneticin) was added at a concentration of
250 mg/ml to the Huh-7 cells stably expressing HCV subgenomic replicons.
The pFK-I389neo/NS3-30/5.1 and pFK-I389luc/NS3-30/5.1 plasmids, which
contain HCV subgenomic replicons (genotype 1b, Con1, GenBank accession
number AJ242654), were kindly provided by Ralf Bartenschlager (Institute of
Hygiene, University of Heidelberg) (Lohmann et al., 1999). The replicons harbor
either neomycin resistance (neoR; pFK-I389neo/NS3-3
0/5.1) or the firefly lucif-
erase (luc; pFK-I389luc/NS3-3
0/5.1) gene at the 50 end (driven by the HCV
IRES), but otherwise are identical and express the HCV nonstructural proteins
(NS3 to NS5B) from the encephalomyocarditis virus IRES as described in
Lohmann et al. (1999).
For siRNA transfections, Huh-7 cells harboring the subgenomic replicon
(pFK-I389neo/NS3-3
0/5.1) were seeded in 60 mm dishes (1 3 106 cells) for
preparation of whole-cell lysates and total RNA extractions. The fluorescently
labeled (Cy3 or Dy547) siRNA duplexes (10–100 nM; described below) were
transfected using Lipofectamine RNAiMAX Transfection Reagent (Invitrogen)
according to the manufacturer’s protocol. Whole-cell lysates and RNA extrac-
tions were prepared at 24, 48, and 72 hr posttransfection. IFNg was used as
a positive control for knockdown of HCV RNA replication at a concentration
of 100 U/ml.
siRNA Sequences
HCV-specific siRNAs were designed based on the HCV subgenomic replicon
(GenBank accession number AJ242654) (Lohmann et al., 1999). The siRNA
design software described in Yiu et al. (2005) was used for the design of
HCV-specific siRNAs and is freely available at http://i.cs.hku.hk/sirna/
software/sirna.php. This software compiles the design software of Ambion,
Jack, Emboss, MPI, Genscript, QIAGEN, Invitrogen, Deqor, and MPI +
Rational for siRNA design. The organism that was selected wasHomo sapiens
and output siRNAs were selected that were predicted from at least four kinds
of software. The top siRNAswere selected for further analysis andwere scored
according to the design criteria outlined by Reynolds and colleagues
(Reynolds et al., 2004). The siRNAs that were selected for analysis had
scoresR 6. The siRNA sequences used to investigate target site accessibility
are listed in Figure 2. Where indicated, duplex siRNAs were formed between
the corresponding sense and antisense strands according to the manufac-
turer’s protocol. The IRES-331 siRNA and the positive control, NS5B-7256
siRNA (also known as NS5B-6367; Wilson et al., 2003), have been previously
reported to be functional siRNAs for inhibition of HCV RNA in cell culture
(Wilson et al., 2003; Yokota et al., 2003; Wilson and Richardson, 2005). The
SL3.3-8589 siRNA was designed against a known stem loop in the NS5B
coding region of the HCV genome (SL3.3; You et al., 2004; Friebe et al.,
2005) as a negative control.
In Vitro Transcription
In vitro transcripts were generated using the MEGAscript T7 kit (Ambion)
according to the manufacturer’s protocol. Briefly, the template DNA was line-
arized with the restriction enzyme ScaI (New England Biolabs), precipitated for
less than 30min, and resuspended in RNase-freewater to a final concentration
of 0.5 mg/ml. The in vitro transcription reaction was set up in a final volume of
20 ml and incubated at 37C for 4 hr. In order to degrade the template DNA,
1 ml of DNase I was added and the reaction was incubated for an additional
15 min at 37C. The in vitro transcripts were then cleaned up using the
MEGAclear kit (Ambion) according to the manufacturer’s protocol. The
concentration was determined by measurement of the absorbance atChemistry & Biology 17,260 nm with an ND-1000 spectrophotometer (NanoDrop Technologies), and
RNA integrity was verified by electrophoresis using an Agilent 2100 bioana-
lyzer with the RNALabChip kit (Agilent Technologies) according to the manu-
facturer’s protocol.
For VRBs, HCV subgenomic replicon RNA transcripts were biotinylated at
the 50 end using the 50-EndTag nucleic acid labeling system (Vector Laborato-
ries) according to the manufacturer’s protocol. The EZ-Link maleimide-
PEG11-biotin label (Thermo Fisher Scientific; 20 mM) was dissolved in
RNase-free dimethyl sulfoxide (Sigma-Aldrich) and the final reaction volume
was 20 ml. Labeled HCV subgenomic replicon RNA was then purified using
the MEGAclear kit (Ambion), and the RNA integrity was verified by agarose
gel electrophoresis and quantified by measurement of the absorbance at
260 nm with an ND-1000 spectrophotometer (NanoDrop Technologies).Atomic Force Microscopy
RNA transcripts were diluted in AFM imaging buffer (20 mM HEPES, 10 mM
MgCl2, 3 mM NiCl2 [pH 7]) to 0.5–2 ng/ml. Prior to RNA deposition, freshly
cleaved mica (grade V2; Ted Pella) was treated with 4 mM NiCl2 for 1 min at
room temperature and washed twice by soaking in 10 ml nuclease-free water
for 10 and 1 min, respectively. The NiCl2-treated mica was then dried under
a stream of nitrogen. Ten microliters of diluted RNA was dropped on the
surface of the NiCl2-treated mica and allowed to adsorb for 5 min at room
temperature. Nonadsorbed RNA was removed by two washes with 10 ml of
nuclease-free water, after which the sample was dried under a stream of
nitrogen and imaged. Imaging was performed at room temperature (22 ±
1C) on a PicoSPM atomic force microscope (Molecular Imaging) in acoustic
mode using aluminum-coated silicon tips with spring constants of 40 N/m
and resonance frequencies between 250 and 325 kHz. Fields of 0.5–3.0 mm
were scanned at 1–1.5 Hz. Images were flattened, and approximate cluster
diameters were determined using PicoScan 5.3.3 software (Molecular
Imaging). Three independently prepared samples were imaged for the HCV
subgenomic replicon RNA transcript, and several areas were scanned for
each sample.VRM Design
A prototype microarray was generated consisting of a dilution series of HCV
subgenomic replicon RNA (5, 25, 100, 125, 250, and 500 ng/ml) as well as
C. jejuni positive- (Cj0373: 50-GTA TCC ACG CAC CTT TAA ATG AAA AAA
CC-30; Cj1119c: 50-GTA CCA TCG CTA TAA CTT TGG CTT-30) and negative-
(Cj1437c: 50-GCC AGA GTG TAT GTG ATT TGG TTG AAC-30) control oligonu-
cleotides. Computer-based homology searches using NCBI BLASTwere used
to ensure that control oligonucleotides contained no homology with the
H. sapiens or HCV genomes, or any of the HCV-specific siRNAs. All oligonucle-
otides were PAGE purified (Invitrogen) and spotted at a final concentration of
500 ng/ml. Each sample was spotted in quadruplicate, interspersed by blank
spots across the array in order to reduce spatial effects (see Figure 3).Preparation of VRM Oligonucleotide Controls
Cy3-labeled short DNA oligonucleotides complementary to the Cj1119c and
Cj0373 oligonucleotides spotted on themicroarrays were prepared as positive
controls and printing quality controls using the Mirus Label-IT Cy3 labeling kit
(Fisher Scientific) according to the manufacturer’s protocol. For normalization
purposes and to account for spot morphology, a DNA probe was designed
against the relatively unstructured luciferase region of the HCV replicon. The
Luc988-42 nt probe (50-GGA AGG GCC ACA CCC TTA GGT AAC CCA GTA
GAT CCAGAGGAA-30 ) was labeled with Cy5 for cross-channel normalization,
using the Mirus Label-IT Cy5 labeling kit (Fisher Scientific). All labeling reac-
tions were carried out according to the manufacturer’s protocol with the
following modifications. Labeling reactions typically contained 5 mg DNA and
2.5 ml Cy3 or Cy5 label in a 50 ml reaction volume. Reactions were incubated
at 37C overnight. Unincorporated dye was removed by ethanol precipitation
and the Cy3-labeled oligonucleotides were resuspended in RNase-free water.
Labeling efficiencies were between 9 and 20 pg/ml as assessed using an ND-
1000 spectrophotometer (NanoDrop Technologies). All oligonucleotides were
PAGE purified prior to the labeling reactions.515–527, May 28, 2010 ª2010 Elsevier Ltd All rights reserved 523
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Microarray printing was carried out using a Nano-Plotter (NP2.1; GeSiM) on
bar-coded Nexterion slide E, epoxysilane-coated substrates (Schott North
America). All probes were diluted in spotting buffer (20 mM HEPES, 50 nM
KCl, 10 mMMgCl2, 1 mM DTT [pH 7.2]) and spotted at 18 ± 2
C and a relative
humidity of 50%. Spotting was carried out in one-tip mode with the nano tip A.
The average drop volume was 140 pl and 7 drops were deposited for a total of
approximately 980 pl/spot. The spotting buffer was also printed on the slides
as a negative control. Postprinting, the slides were left in the printer for 30 min
to dry before storage at 80C until use.VRM Hybridization and Data Analysis
VRM hybridizations were performed between single-stranded, fluorophore-
labeled antisense (guide) siRNAs and the HCV replicon RNA under native (non-
denaturing) conditions in order to maintain RNA secondary structure. All
solutions were prepared with nuclease-free water and all hybridizations were
performed at 37C unless otherwise indicated. All slides were blocked in 43
SSC, 0.1% ultrapure nonacetylated BSA (Ambion) for 15 min at 37C and
washed five times with nuclease-free water at room temperature for 1 min
each. The slides were dried prior to the hybridization reaction by centrifugation
at 200 3 g for 5 min. Hybridizations were performed in 13 Hyb buffer (20 mM
HEPES [pH 7.8], 50 mM KCl, 10 mM MgCl2, 1 mM DTT) supplemented with
100 mg/ml yeast tRNAs, 0.625 mg/ml salmon sperm DNA, 40 U RNase-OUT
(Invitrogen), 300 pg/ml Cy3-Cj1119c oligonucleotide, 900 pg/ml Cy3-Cj0373
oligonucleotide, 30 nM Cy5-Luc988-42 nt, and 1 mM siRNA in a 40 ml reaction
volume. The hybridization reactions were denatured at 65C for 5 min and then
incubated at 37C for 10 min prior to application to the VRMs. Both the cover-
slips and microarray slides were preheated to 37C for 10 min prior to hybrid-
ization. Hybridizations were performed for 45 min to 1 hr at 37C under glass
coverslips (24 3 20 mm) in a humidified SlideBooster hybridization chamber
(Olympus Advalytix). For hybridizations carried out under denaturing condi-
tions, hybridization buffer was replaced with a denaturing 50% DIG Easy
Hybridization solution (Roche) and hybridizations (target microarray + hybrid-
ization solution) were initially heated to 65C and slowly cooled to 37C over
the 1 hr hybridization period. After hybridization, microarrays were washed
twice with 13 SSC + 0.05% SDS, twice with 0.53 SSC, and twice with 0.13
SSC at 45C for 5 min each. The slides were spun dry by centrifugation at
200 3 g for 5 min and stored in light-tight containers until they were scanned.
VRMs were scanned using the VersArray Chipreader (Bio-Rad) according to
the recommendations of the manufacturer.
Spot quantification, signal normalization, and data analysis were performed
using Array-Pro Analyzer image analysis software (version 4.5; MediaCyber-
netics). Net signal intensities were obtained by local-ring background subtrac-
tion (net intensity = raw intensity – background). For normalization purposes
and to account for spot morphology, the ratio of the signal intensities of the
siRNAs (Cy3 channel) to that of the Luc988-42 nt normalization control (Cy5
channel) of the spots containing HCV RNA was used for further analysis
(normalized net intensity). The Cy3-labeled C. jejuni oligonucleotides were
used to scale the intensities between microarrays. A single HCV replicon
RNAconcentrationwas chosen for analysis (125 ng/ml) because it had a greater
than 2-fold signal-to-noise ratio without reaching saturation for all HCV-
specific siRNAs. Signal intensities for quadruplicate spots were averaged,
and all hybridizations were carried out in duplicate or triplicate.In Vitro Hybridizations for VRBs
One microgram of biotinylated HCV subgenomic replicon RNA was diluted in
13 hybridization buffer (20 mM HEPES [pH 7.8], 50 mM KCl, 10 mM MgCl2,
1 mM DTT) supplemented with 0.625 mg/ml salmon sperm DNA, 50 mg/ml
yeast tRNA, and 0.2 U/ml SUPER-In RNase Inhibitor (Ambion) in a total volume
of 20 ml. The siRNAs were diluted to final concentrations ranging from 0.01 to
1 mM. Hybridizations were then carried out at 37C for 30 min. For hybridiza-
tions carried out under denaturing conditions, the samples were prepared as
described above, except the reactions were first heat denatured at 80C for
15 min, followed by incubation on ice for 2 min, prior to hybridization at
37C for 30 min. In order to account for background binding of siRNA to the
beads, control reactions were carried out in the absence of HCV subgenomic
replicon RNA.524 Chemistry & Biology 17, 515–527, May 28, 2010 ª2010 ElsevierMagnetic Microbead Preparation and Immobilization of RNA
for VRBs
Approximately 5 3 106 streptavidin-coated Dynabeads M-280 (Invitrogen)
were used per sample. After resuspension, beads were washed three times
with 13 B&W buffer (23 B&W buffer: 10 mM Tris-HCl [pH 7.5], 2 M NaCl)
and then washed twice with solution A (0.1 M NaOH, 0.05 M NaCl) at room
temperature. Finally, the beads were washed twice with hybridization buffer
at room temperature prior to incubation with the hybridization reactions.
The in vitro hybridization reactions in solution were then added to the strep-
tavidin-coated Dynabeads and were then incubated at 37C for 20 min to
capture the biotinylatedHCV subgenomic replicon RNAs. After immobilization,
the VRBs were washed twice with 23 SSC and twice with 13 SSC, and resus-
pended in 10 ml of RNase-free PBS. The beads were visualized by fluores-
cence using an Olympus BX51 fluorescent microscope (Olympus Optical).
All hybridization reactions were carried out in triplicate.
VRB Image and Data Analysis
The quantification of signal intensities from the VRBs was performed using
Image-Pro Plus 4.5 software (Media Cybernetics) by calculating the integrated
optical density (IOD) from individual beads. Net signal intensities were ob-
tained by local-ring background subtraction (net = raw – background). The
net signal intensity for each bead was then normalized to the area of the
bead (net IOD/area) and averaged for approximately 100 beads per image.
For normalization purposes, the net IODs from the control hybridization
reactions carried out in the absence of HCV subgenomic replicon RNA were
subtracted from the net IODs. For each siRNA, hybridization experiments con-
ducted using native HCV RNA and HCV RNA that was heat denatured during
hybridization (80C) were carried out at final siRNA concentrations ranging
from 0.01 to 1 mM. From these hybridizations, standard curves for native
and denatured HCV RNA were generated from linear least-squares fitting of
the net IODs versus siRNA concentration in each case. Target site accessibility
was assessed by the ratio of the slope of the siRNA hybridization to native HCV
RNA over the slope of the siRNA hybridization to denatured HCV RNA.
Western Blot Analysis
For detection of HCV proteins, whole-cell lysates were prepared from Huh-7
cells harboring subgenomic replicons after treatment with siRNAs as
described for 24, 48, or 72 hr. Cells were washed twice with PBS and lysed
with a lysis buffer consisting of 50 mM Tris-HCl (pH 6.8), 2% SDS, 10% glyc-
erol, 100 mM DTT, and 0.1% bromophenol blue (prepared initially without the
DTT and bromophenol blue). Complete protease inhibitor cocktail (Roche
Diagnostics) was added to each extract to a final concentration of 13. The
protein concentration of each sample was quantified using the Bio-Rad DC
protein assay according to the manufacturer’s protocol. Prior to loading,
10% DTT and bromophenol blue (1:1) was added to each sample and the
samples were heated to 95C for 5min and cooled on ice. Approximately 60 mg
of protein per well was loaded for SDS-PAGE (10% resolving, 4% stacking
gel). The resolved proteins were transferred to a Hybond-P PVDF membrane
(GE Healthcare). The membrane was blocked for 1 hr with 5% skim milk in
TBS-Tween and probed for the HCV NS5A protein with a mouse monoclonal
anti-NS5A antibody (0.2 mg/ml; Virostat) followed by an HRP-conjugated
goat anti-mouse IgG antibody (1:1000 dilution; Jackson ImmunoResearch
Laboratories). As a loading control, the membranes were stripped using Re-
blot Plus Strong Solution (Millipore) according to the manufacturer’s protocol,
and reprobed with a mouse anti-PTP1D/SHP2 primary antibody (1:1000 dilu-
tion; Sigma) with the same secondary antibody as described above. Protein
bands were visualized by usingWestern Lightning western blot chemilumines-
cence reagents (PerkinElmer) according to the manufacturer’s protocol.
RNA Isolation and Northern Blot Analysis
Total RNA was isolated from siRNA-transfected HCV subgenomic replicon-
harboring cells at 24, 48, and 72 hr posttransfection using the RNeasy extrac-
tion kit (QIAGEN). Approximately 0.5 mg/well of total RNA was loaded onto
a 1% agarose gel. Biotinylated negative-sense probes complementary to
the HCV genome NS5B region nt 6648–7770 (GenBank accession number
AJ242654) and the b-actin gene (GenBank accession number X00351) were
synthesized using the MEGAscript T7 kit (Ambion). In vitro transcriptions
were performed as described above with the inclusion of biotin-11-UTP andLtd All rights reserved
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unlabeled CTP, respectively, and were carried out at 37C overnight. DNA
template was removed by DNase I digestion, and biotinylated RNA was puri-
fied using the MEGAclear kit (Ambion) with elution in RNase-free water. The
biotinylated negative-sense probes were used at a final concentration of
2.2 ng/ml and 0.133 ng/ml for the HCV and b-actin probes, respectively.
Northern blotting and hybridization were carried out using the NorthernMAX
kit (Ambion) and Hybond XL nylon membranes (GE Healthcare). The bound
riboprobes were detected using the Chemiluminescent Nucleic Acid Detection
Module (Pierce) according to the manufacturer’s protocol.
Quantitative PCR
For quantitative PCR (qPCR) analyses, Huh-7 cells harboring subgenomic
replicons were treated with siRNAs as described. At 24 hr posttransfection,
total RNA was isolated using the RNeasy extraction kit (QIAGEN), followed
by a 30 min digestion with DNase I (Ambion). Total RNA was then purified
with the DNA-free kit (Ambion). The concentration was determined by
measurement of the absorbance at 260 nm with an ND-1000 spectrophotom-
eter (NanoDrop Technologies), and RNA integrity was verified by agarose gel
electrophoresis. Five hundred nanograms of total RNA was used for cDNA
synthesis using the Superscript II kit (Invitrogen) according to the manufac-
turer’s protocol. Quantitative PCR was performed on an iCycler (Bio-Rad)
using Platinum SYBR Green Supermix (Invitrogen) containing 20 nM fluores-
cein (Bio-Rad) with primers directed against the HCV IRES region (50-GTC
TGC GGA ACC GGT GAG TA-30 and 50-GCC CAA ATC TCC AGG CAT T-30),
and 18S rRNA (50-GCG ATG CGG CGG CGT TAT TC-30 and 50-CAA TCT
GTC AAT CCT GTC CGT GTC C-30) and GAPDH (50-AGG CTG TGG GCA
AGG TCA TCC-30 and 50-AGT GGG TGT CGC TGT TGA AGT CA-30) were
used as reference genes. A 20 ml reaction was assembled according to the
manufacturer’s protocol. For data analysis, the 2DDCt methodwas used (Livak
and Schmittgen, 2001), and mean fold changes relative to untreated HCV sub-
genomic replicon RNA-harboring cells are presented. Each qPCR experiment
was carried out in triplicate.
Data Sets and Bioinformatic Methods
The sequence data set used for hepacivirus analyses was created by Dr. Peter
Simmonds using the Simmonic Sequence Editor version 1.6 (http://www.
picornavirus.org/software) (Simmonds and Smith, 1999; Simmonds et al.,
2004; Davis et al., 2008) from complete genome sequences downloaded
from GenBank. The 83 published HCV genotype 1b sequences were used
for the bioinformatics analyses.
MFEs were calculated for consecutive 150-base fragments (in 2-base incre-
ments) of each sequence from each alignment using the folding energy scan in
the Simmonic Sequence Editor program from a locally compiled copy of UNA-
Fold (Markham and Zuker, 2005) running onWindows XP. For each sequence,
MFE differences from the null expectation (MFED) (Workman and Krogh, 1999;
Davis et al., 2008) were calculated by the parallel submission of 50 sequence
scrambles using the NDR algorithm in the Simmonic Sequence Editor, which
retains dinucleotide frequency biases (Simmonds et al., 2004; Davis et al.,
2008). Results are expressed asMFEDs (i.e., the%difference inMFEs of native
and scrambled sequences, calculated as {[(MFENative/MFEScrambled) – 1]3 100}
(Workman and Krogh, 1999; Davis et al., 2008).
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